Stryker's spine division to drive Q1 sales: 5 insights

Written by Mackenzie Garrity | April 18, 2018 | Print  |

Stryker's neurotechnology and spine division is anticipated to see growth in the first quarter of 2018, pushing the company's overall growth, according to Zacks.

Here are five insights.

1. Recently, Stryker's spine segment has seen a push in demand for target coil and 3-D printed interbody tritanium products.

2. Zacks estimates Stryker's spine and neurotechnology revenues to be around $561 million in the first quarter of 2018, an 8.9 percent increase year-over-year.

3. Stryker's last reported quarter put spine and neurotechnology sales at $586 million, up 10.3 percent year-over-year. The company attributed the jump to organic growth.

4. Revenues for the first quarter of 2018 are anticipated to hit $187 million within the spine segment, a 1.6 percent year-over-year increase.

5. Revenues for the first quarter of 2018 are projected to hi $373 million within the neurotechnology segment, representing a 12.7 percent year-over-year increase.

More articles on devices and implants:
NovoStitch Pro Meniscal Repair System receives FDA 510(k) clearance: 4 insights
Global spinal fusion devices market to grow at 4.6% CAGR through 2025: 4 observations
Dr. Richard Moore performs 1st surgery with Zimmer Biomet's Persona Trabecular Metal Tibia: 5 notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers